Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Novel somatic mutations in UBA1 as a cause of VEXAS syndrome
Blood, 2021-07, Vol.137 (26), p.3676-3681
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction
Blood, 2015-03, Vol.125 (12), p.1932-1935
2015
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis
Blood, 2014-08, Vol.124 (8), p.1296-1299
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial
PLoS medicine, 2021-01, Vol.18 (1), p.e1003454
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen
Haematologica (Roma), 2016-02, Vol.101 (2), p.e69
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies
Histopathology, 2011-01, Vol.58 (1), p.90-105
2011
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk
Journal of clinical oncology, 2022-09, Vol.40 (25), p.2889-2900
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma
Journal of clinical oncology, 2023-08, Vol.41 (23), p.3945-3955
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma
Cytometry. Part B, Clinical cytometry, 2016-01, Vol.90 (1), p.61-72
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial
Bone marrow transplantation (Basingstoke), 2024-03, Vol.59 (3), p.431-434
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Bortezomib consolidation post‐ASCT as frontline therapy for multiple myeloma deepens disease response and MRD‐negative rate whilst maintaining QOL and response to re‐treatment at relapse
British journal of haematology, 2019-06, Vol.185 (5), p.948-951
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial
The Lancet. Haematology, 2023-02, Vol.10 (2), p.e93-e106
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
BMJ open, 2021-02, Vol.11 (2), p.e041296-e041296
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
BMJ open, 2022-11, Vol.12 (11), p.e063037-e063037
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Measuring disease levels in myeloma using flow cytometry in combination with other laboratory techniques: Lessons from the past 20 years at the Leeds Haematological Malignancy Diagnostic Service
Cytometry. Part B, Clinical cytometry, 2016-01, Vol.90 (1), p.54-60
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial
BMJ open, 2022-06, Vol.12 (6), p.e056147
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Immunoglobulin M Concentration in Waldenström Macroglobulinemia: Correlation With Bone Marrow B Cells and Plasma Cells
Clinical lymphoma, myeloma and leukemia, 2013-04, Vol.13 (2), p.211-213
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Reply to M. Roschewski et al
Journal of clinical oncology, 2014-02, Vol.32 (5), p.476-477
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
High-Sensitivity Analysis of Normal B-Cell Subsets in MBL and Untreated CLL Identifies Patients with Sub-Optimal Sars-Cov-2 Antibody Responses
Blood, 2022-11, Vol.140 (Supplement 1), p.7032-7033
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia
British journal of haematology, 2024-08
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
The New England journal of medicine, 2024-01, Vol.390 (4), p.326-337
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia
Leukemia, 2024-04, Vol.38 (4), p.822-828
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK’s Haematological Malignancy Research Network
Cancer epidemiology, 2024-02, Vol.88, p.102513-102513, Article 102513
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Epigenetic control of the protocadherin-gamma locus provides a potential source of cell surface codes in B cell differentiation
The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.153-153.17
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Pembrowm: Results of a Multi-Centre Phase II Trial Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia
Blood, 2022-11, Vol.140 (Supplement 1), p.3624-3626
2022
Volltextzugriff (PDF)
1 – 25 von 100
Suche als RSS-Feed
Aktive Filter
ThemaBiological And Medical Sciences
Suchergebnisse filtern
Filter anzeigen